MCF7 and T47D cells were obtained from ATCC (Manassas, Virginia) and authenticated by Microsynth AG (Balgach, Switzerland) on October 7, 2016. Profiling of human cell lines was done using highly-polymorphic short tandem repeat loci (STRs). STR loci were amplified using the PowerPlex® 16 HS System (Promega, Madison, Wisconsin). Fragment analysis was done on an ABI3730xl (Thermo Fisher Scientific, Waltham, Massachusetts) and the resulting data were analyzed using GeneMarker HID software (Softgenetics, State College, Pennsylvania).
Cells were stably transfected with expression plasmid pcDNA3.1 containing hemagglutinin (HA)-tagged PGRMC1 wild-type or HA-tagged PGRMC1 mutants S57A, S181A and S57A/S181A, as described elsewhere [35 (link)]. MCF7 and T47D cells were maintained in RPMI 1640 medium (Thermo Fisher Scientific, Waltham, Massachusetts), supplemented with 10% fetal bovine serum (Thermo Fisher Scientific, Waltham, Massachusetts), 100 units/ml penicillin/streptomycin (Thermo Fisher Scientific, Waltham, Massachusetts) and 25 mM HEPES (Thermo Fisher Scientific, Waltham, Massachusetts) in a humidified incubator at 37°C with 5% CO2.
Free full text: Click here